The VITAL Amyloidosis Study, a Global Phase 3, Efficacy and Safety Study of NEOD001 in Patients With AL Amyloidosis

Clinical trial NCT02312206 · TERMINATED

Trial details

NCT number: NCT02312206
Sponsor: Prothena Biosciences Ltd.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Primary Systemic (AL) Amyloidosis

Start date: 2015-02-01
Primary completion: 2018-05-01
Enrollment: 260

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.